Who owns OLEMA PHARMACEUTICALS INC?
- Ticker: OLMA
- CUSIP Number: 68062p106
Tip: Access positions for across all investors
Analyze quarterly positions in Olema Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Olema Pharmaceuticals stock
Who bought or sold OLEMA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
|---|---|---|---|---|---|---|
| BVF | 6.7M | $320M | 100% | Dec 2020 | ||
| Logos Global Management | 3.7M | $180M | 100% | Dec 2020 | ||
| Henderson Group | 3.6M | $161M | 100% | Dec 2020 | ||
| Cormorant Asset Management | 3.2M | $148M | 100% | Dec 2020 | ||
| RA Capital Management | 2.2M | $103M | 100% | Dec 2020 | ||
| Wellington Management Company | 2.1M | $96M | 100% | Dec 2020 | ||
| VR Adviser | 1.5M | $74M | 100% | Dec 2020 | ||
| Citadel Advisors | 1.4M | $69M | 100% | Dec 2020 | ||
| Vivo Capital | 1.2M | $60M | 100% | Dec 2020 | ||
| venBio Select Advisor | 877k | $36M | 100% | Dec 2020 | ||
| Foresite Capital Management IV | 818k | $39M | 100% | Dec 2020 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Olema Pharmaceuticals? |
||||||
| Vanguard Group | 804k | $38M | 100% | Dec 2020 | ||
| Deerfield Management Company | 696k | $34M | 100% | Dec 2020 | ||
| BlackRock | 685k | $33M | 100% | Dec 2020 | ||
| FMR | 655k | $32M | 100% | Dec 2020 | ||
| OrbiMed Advisors | 651k | $31M | 100% | Dec 2020 | ||
| Hillhouse Capital Advisors | 620k | $30M | 100% | Dec 2020 | ||
| Invesco | 530k | $26M | 100% | Dec 2020 | ||
| Franklin Resources | 370k | $18M | 100% | Dec 2020 | ||
| Ameriprise Financial | 367k | $18M | 100% | Dec 2020 | ||
| Driehaus Capital Management | 273k | $13M | 100% | Dec 2020 | ||
| Avidity Partners Management | 270k | $13M | 100% | Dec 2020 | ||
| Artal Group | 261k | $13M | 100% | Dec 2020 | ||
| Federated Investors | 260k | $13M | 100% | Dec 2020 | ||
| Tybourne Capital Management | 260k | $8.6M | 0% | Mar 2021 | ||
| Arrowpoint Asset Management | 253k | $12M | 100% | Dec 2020 | ||
| Pictet Asset Management | 161k | $7.7M | 100% | Dec 2020 | ||
| Jpmorgan Chase & Co | 74k | $3.5M | 100% | Dec 2020 | ||
| Goldman Sachs Group | 55k | $2.7M | 100% | Dec 2020 | ||
| UBS Group | 53k | $2.6M | 100% | Dec 2020 | ||
| Morgan Stanley | 46k | $2.2M | 100% | Dec 2020 | ||
| Susquehanna International | 43k | $2.1M | 100% | Dec 2020 | ||
| Geode Capital Management | 27k | $1.3M | 100% | Dec 2020 | ||
| Atom Investors | 25k | $1.2M | 100% | Dec 2020 | ||
| Parametric Portfolio Associates | 25k | $1.2M | 100% | Dec 2020 | ||
| CalPERS | 24k | $1.2M | 100% | Dec 2020 | ||
| Marshall Wace North America | 24k | $1.1M | 100% | Dec 2020 | ||
| Hrt Financial | 23k | $1.1M | 100% | Dec 2020 | ||
| ExodusPoint Capital Management | 22k | $1.0M | 100% | Dec 2020 | ||
| Millennium Management | 19k | $892k | 100% | Dec 2020 | ||
| Pinz Capital Management | 18k | $856k | 100% | Dec 2020 | ||
| Sphera Funds Management | 15k | $731k | 100% | Dec 2020 | ||
| Jefferies Group | 15k | $726k | 100% | Dec 2020 | ||
| Northern Trust | 14k | $668k | 100% | Dec 2020 | ||
| SG Americas Securities | 12k | $591k | 100% | Dec 2020 | ||
| Tibra Equities Europe | 12k | $591k | 100% | Dec 2020 | ||
| Mirabella Financial Services | 11k | $505k | 100% | Dec 2020 | ||
| Qube Research & Technologies | 8.9k | $427k | 100% | Dec 2020 | ||
| Citigroup | 6.9k | $332k | 100% | Dec 2020 | ||
| Windsor Creek Advisors | 6.0k | $288k | 100% | Dec 2020 | ||
| Maven Securities | 5.6k | $278k | 100% | Dec 2020 | ||
| M^T Bank Corporation | 5.3k | $254k | 100% | Dec 2020 | ||
| Athanor Capital | 5.2k | $250k | 100% | Dec 2020 | ||
| Tower Research Capital | 570.00 | $27k | 100% | Dec 2020 | ||
| Kinloch Capital | 500.00 | $24k | 100% | Dec 2020 | ||
| Bank of America Corporation | 95.00 | $5.0k | 100% | Dec 2020 | ||
| Private Capital Group | 31.00 | $1.0k | 100% | Mar 2021 | ||
| Wells Fargo & Company | 30.00 | $999.999000 | 100% | Dec 2020 | ||